According to a new report published by Allied Market Research, titled, “Alopecia Treatment Market by Drug Type (Minoxidil, Finasteride, and Other Drug Types), Indication (Androgenic Alopecia, Alopecia Areata, Alopecia Totalis, and Others), and Distribution Channel (Hospitals Pharmacies, Drug Stores & Retail Pharmacies, and Online Pharmacies): Global Opportunity Analysis and Industry Forecast, 2019–2026.” According to the analyst of AMR, the global alopecia treatment market garnered $2.73 billion in 2018, and is expected to reach $3.93 billion by 2026, growing at a CAGR of 4.6% from 2019 to 2026.
Get Sample PDF Report at: https://www.alliedmarketresearch.com/request-sample/6310
Alopecia Treatment Market Overview-
Surge in chronic diseases leading to hair loss, supportive policies & rise in expenditure on healthcare, and increase in geriatric population drive the growth of the global alopecia treatment market. However, lack of sufficient demand from underdeveloped countries hinder the market growth. On the other hand, untapped potential from emerging economies is expected to offer lucrative opportunities in coming years.
Alopecia Treatment Market Segmentation:
Androgenic alopecia segment held the maximum share-
Based on indication, the androgenic alopecia segment contributed to the largest market share in 2018, accounting for nearly two-fifths of the global alopecia treatment market, and is estimated to maintain its lead status by 2026. This is due to innovations in healthcare infrastructure, increase in adoption of androgenic alopecia treatment drugs, and rise in number of androgenic alopecia disorder patients. However, the alopecia totalis segment is expected to register the highest CAGR of 5.5% during the forecast period, owing to rise in prevalence and surge in demand for therapeutics.
North America region held the highest share-
Based on region, North America accounted for the major market share, accounting for nearly half of the total market share of the global alopecia treatment market in 2018, and is estimated to maintain its highest share during the forecast period. This is attributed to presence of advanced healthcare facilities along with skilled medical professionals and rise in number of R&D activities. However, Asia-Pacific is estimated to register a CAGR of 5.9% from 2019 to 2026. This is due to surge in number of hospitals equipped with advanced medical facilities, favorable healthcare reforms, and technological advancements in healthcare.
Minoxidil segment held the lion share-
Based on drug type, the minoxidil segment held the largest market share in 2018, accounting for more than two-fifths of the global alopecia treatment market, and is expected to continue its leadership status during the forecast period. This is attributed to rise in various conditions such as arthritis, hypertension, depression, and cancer treatment that leads to hair loss along with rise in air & water pollution. However, the finasteride is projected to grow at the fastest CAGR of 5.2% from 2019 to 2026, owing to factors including surge in cases of hair fall & hair problems, abundance of raw material, technological advancements in alopecia treatment, and rapid industrialization.
For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/6310
Alopecia Treatment Market: By Region Outlook
North America (U.S., Canada)
Europe (France, Germany, UK, Italy, Spain, Netherlands, Austria)
Asia Pacific (Japan, China, India, Malaysia, Indonesia, South Korea)
Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)
Important Questions Being Answered by the Alopecia Treatment Market Report:
What is the Alopecia Treatment market size and growth?
What are the prominent and latest trends impacting the market?
Which is the largest regional market for Alopecia Treatment?
Key market players discussed in the report include Capillus, LLC, Cipla Inc., Daiichi Sankyo Company, Limited, GlaxoSmithKline Plc, Johnson & Johnson, Merck & Co., Inc., Sun Pharmaceutical Industries Ltd., Transitions Hair, Vitabiotics Ltd., and Vita-Cos-Med Klett-Loch GmbH.
Top Trending Report:-
Companion Diagnostic Market Size, Share & Growth Outlook 2022-2030
Nuclear Medicine Market Size, Share & Growth Outlook 2022-2030
Avenue Basic Plan | Library Access | 1 Year Subscription |
Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.
Avenue Library Subscription | Request for 14 days free trial of before buying: https://www.alliedmarketresearch.com/avenue/trial/starter
“We have also published few syndicated market studies in the similar area that might be of your interest.”
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.